The biopharmaceutical companies of PILMA are devoted to making patients’ lives better through investing in the development of ground-breaking cures. The men and women of the building construction trades who develop and maintain biopharmaceutical facilities are also lifelong patients. They are embedded in every facet of the companies’ DNA, from the infrastructure investment to the utilization of new medications.
- New cures – The biopharmaceutical industry’s quest for new discoveries is making it possible for patients to effectively manage chronic and once life-threatening illnesses.
- Controlling costs – The effective managing of chronic conditions with medication has greatly reduced the number of costly hospital stays for patients allowing them to stay productive on the job.
- Purchase power – Union members are a large constituent purchasing group of biopharmaceutical products through benefits plans negotiated for their members.
- Pension investment – Union pension plans play a large role as shareholders of biopharmaceutical company portfolios.